Get the Stockscreener App
0.4115
7.45%
-0.033
After Hours:
.40
-0.0115
-2.79%
Immunoprecise Antibodies Ltd Stock (IPA) Forecast
The Immunoprecise Antibodies Ltd (IPA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.7313, representing a +1,293% increase from the current price of $0.4115. The highest analyst price target is $5.307, and the lowest is $6.1556.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IPA Price Target
Average 5.0098
(+1,117% Upside)
Is Immunoprecise Antibodies Ltd (IPA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.31 | Neutral |
| STOCH(9,6) | 56.73 | Neutral |
| STOCHRSI(14) | 38.04 | Neutral |
| MACD(12,26) | -0.0392 | Buy |
| ADX(14) | 19.87 | Neutral |
| William %R | -66.00 | Neutral |
| CCI(14) | -59.78 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4408
Sell
|
0.451
Sell
|
| MA20 |
0.4816
Sell
|
0.4782
Sell
|
| MA50 |
0.5592
Sell
|
0.5629
Sell
|
| MA100 |
0.7017
Sell
|
0.7087
Sell
|
| MA200 |
1.0604
Sell
|
0.9787
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, IPA could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on IPA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.31 indicates that IPA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 56.73 indicates that IPA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.04 indicates that IPA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.87 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -59.78 indicates that IPA is still oversold but not to an extreme extent.
Long-term IPA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immunoprecise Antibodies Ltd financial reports and earnings history, Immunoprecise Antibodies Ltd (IPA) stock could reach $11.86 by 2030, $59.71 by 2040 and $25.66 by 2050. See the projected annual prices until 2050 of the Immunoprecise Antibodies Ltd stock below:
- Immunoprecise Antibodies Ltd (IPA) is expected to reach an average price of $8.3803 in 2035, with a high prediction of $9.3164 and a low estimate of $8.4543. This indicates an $1,937% rise from the last recorded price of $0.4115.
- Immunoprecise Antibodies Ltd (IPA) stock is projected to chart a bullish course in 2040, with an average price target of $57.35, representing an $13,838% surge from its current level. The forecast ranges from a conservative $58.12 to a sky-high $59.71.
- Our analysts predict Immunoprecise Antibodies Ltd (IPA) to jump 10,796% by 2045, soaring from $44.61 to an average price of $44.84, potentially reaching $45.79. While $44.61 is the low estimate, the potential upside is significant.
- Immunoprecise Antibodies Ltd (IPA) stock is expected to climb by 2050, reaching an average of $24.73, a $5,911% jump from its current level. However, a wide range of estimates exists, with high and low targets of $25.66 and $24.78, respectively, highlighting the market's uncertainty.
Immunoprecise Antibodies Ltd Stock (IPA) Year by Year Forecast
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2024
Our forecast for IPA stock price in 2024 now indicates an average price target of $3.6956 with a high forecast of $7.146 and a low forecast of $0.2453. The average prediction reflects an increase of +798.09% from the last recorded price of $0.4115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $5.8056 | $6.1556 | $5.307 | +1,311% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2025
Immunoprecise Antibodies Ltd Stock (IPA) is expected to reach an average price of $5.0098 in 2025, with a high prediction of $5.9086 and a low estimate of $4.1111. This indicates an +1,117% rise from the last recorded price of $0.4115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.4889 | $5.4502 | $5.6299 | +1,234% |
| February, 2025 | $6.2235 | $5.9076 | $5.8635 | +1,412% |
| March, 2025 | $5.3181 | $5.7781 | $5.361 | +1,192% |
| April, 2025 | $5.5714 | $5.7914 | $5.5941 | +1,254% |
| May, 2025 | $5.926 | $5.946 | $5.5874 | +1,340% |
| June, 2025 | $5.2807 | $5.282 | $5.4647 | +1,183% |
| July, 2025 | $5.4639 | $4.958 | $5.1839 | +1,228% |
| August, 2025 | $6.7186 | $5.8512 | $5.9086 | +1,533% |
| September, 2025 | $4.8832 | $5.0232 | $5.7159 | +1,087% |
| October, 2025 | $4.6764 | $4.3205 | $3.9714 | +1,036% |
| November, 2025 | $3.7011 | $4.1111 | $4.4901 | +799.41% |
| December, 2025 | $5.2743 | $4.1597 | $4.9043 | +1,182% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2026
The predicted value for Immunoprecise Antibodies Ltd (IPA) in 2026 is set at an average of $3.3513. Estimates vary from a peak of $5.01 to a trough of $1.6927, indicating an +714.42% surge from the present price of $0.4115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.799 | $4.979 | $5.01 | +1,066% |
| February, 2026 | $2.3436 | $3.4274 | $4.1463 | +469.52% |
| March, 2026 | $2.5682 | $2.4522 | $2.9396 | +524.11% |
| April, 2026 | $3.1815 | $3.4469 | $3.8542 | +673.14% |
| May, 2026 | $2.5961 | $2.6875 | $2.4675 | +530.89% |
| June, 2026 | $2.3502 | $2.5734 | $2.2548 | +471.14% |
| July, 2026 | $1.724 | $1.734 | $1.5315 | +318.96% |
| August, 2026 | $2.2086 | $1.6927 | $1.7586 | +436.72% |
| September, 2026 | $2.0219 | $2.2273 | $2.0173 | +391.35% |
| October, 2026 | $2.6965 | $2.2579 | $2.0365 | +555.29% |
| November, 2026 | $3.1911 | $3.1638 | $2.8938 | +675.49% |
| December, 2026 | $2.2744 | $2.6943 | $2.6871 | +452.71% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immunoprecise Antibodies Ltd (IPA) is $1.174, with a high forecast of $2.2181 and a low forecast of $0.1299. This indicates an +185.29% increase from the last price of $0.4115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.039 | $2.2304 | $2.2181 | +395.51% |
| February, 2027 | $1.8037 | $1.965 | $1.7928 | +338.31% |
| March, 2027 | $2.1669 | $1.9123 | $1.8509 | +426.59% |
| April, 2027 | $2.2616 | $2.2542 | $2.1316 | +449.59% |
| May, 2027 | $1.8962 | $2.0889 | $1.9302 | +360.80% |
| June, 2027 | $1.6895 | $2.0148 | $2.1308 | +310.56% |
| July, 2027 | $1.8741 | $1.5781 | $1.6041 | +355.42% |
| August, 2027 | $1.8087 | $1.50 | $1.6527 | +339.54% |
| September, 2027 | $0.922 | $1.202 | $1.396 | +124.05% |
| October, 2027 | $0.4166 | $0.5066 | $0.8325 | +1.24% |
| November, 2027 | $0.1662 | $0.2612 | $0.3748 | -59.61% |
| December, 2027 | $0.1345 | $0.1299 | $0.5614 | -67.32% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2028
In 2028, Immunoprecise Antibodies Ltd (IPA) is projected to reach an average price of $10.15, with a high projection of $20.29 and a low estimate of $0.00358. This indicates an +2,365% rise from the last price of $0.4115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0491 | $0.1818 | $0.0805 | -88.07% |
| February, 2028 | $15.63 | $0.00358 | $13.62 | +3,698% |
| March, 2028 | $13.49 | $15.24 | $13.77 | +3,179% |
| April, 2028 | $18.84 | $16.69 | $17.16 | +4,479% |
| May, 2028 | $18.18 | $18.03 | $18.35 | +4,318% |
| June, 2028 | $19.78 | $18.76 | $19.25 | +4,707% |
| July, 2028 | $20.00 | $19.77 | $19.89 | +4,760% |
| August, 2028 | $20.91 | $20.27 | $20.28 | +4,983% |
| September, 2028 | $18.57 | $19.34 | $20.29 | +4,414% |
| October, 2028 | $17.90 | $18.28 | $18.41 | +4,251% |
| November, 2028 | $18.40 | $18.02 | $17.88 | +4,371% |
| December, 2028 | $17.75 | $17.91 | $18.08 | +4,213% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2029
The 2029 price forecast for Immunoprecise Antibodies Ltd Stock (IPA) is $14.10 on average, with a high prediction of $17.31 and a low estimate of $10.88. This represents an +3,326% increase from the previous price of $0.4115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $16.87 | $17.68 | $17.31 | +3,999% |
| February, 2029 | $16.94 | $17.36 | $16.97 | +4,018% |
| March, 2029 | $15.88 | $16.35 | $16.68 | +3,760% |
| April, 2029 | $15.87 | $15.82 | $16.00 | +3,757% |
| May, 2029 | $16.36 | $16.32 | $16.00 | +3,876% |
| June, 2029 | $15.15 | $16.33 | $16.27 | +3,581% |
| July, 2029 | $13.86 | $14.25 | $14.83 | +3,268% |
| August, 2029 | $13.70 | $14.14 | $14.14 | +3,230% |
| September, 2029 | $13.98 | $13.52 | $13.66 | +3,298% |
| October, 2029 | $13.92 | $13.99 | $14.01 | +3,283% |
| November, 2029 | $11.64 | $13.10 | $13.45 | +2,728% |
| December, 2029 | $11.31 | $10.88 | $11.23 | +2,648% |
Immunoprecise Antibodies Ltd Stock (IPA) Price Forecast for 2030
Immunoprecise Antibodies Ltd Stock (IPA) is expected to reach an average price of $9.2465 in 2030, with a high forecast of $11.86 and a low forecast of $6.6346. This signifies an +2,147% surge from the last price of $0.4115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.15 | $11.59 | $11.86 | +2,610% |
| February, 2030 | $10.32 | $10.33 | $10.78 | +2,409% |
| March, 2030 | $9.8591 | $10.01 | $9.9622 | +2,296% |
| April, 2030 | $9.2434 | $9.2161 | $9.4915 | +2,146% |
| May, 2030 | $8.6399 | $8.5553 | $8.2307 | +2,000% |
| June, 2030 | $8.6592 | $8.7692 | $8.5946 | +2,004% |
| July, 2030 | $8.2157 | $8.3357 | $8.3365 | +1,897% |
| August, 2030 | $8.725 | $8.843 | $8.7577 | +2,020% |
| September, 2030 | $8.3163 | $8.5142 | $8.1942 | +1,921% |
| October, 2030 | $7.1753 | $7.3808 | $7.5111 | +1,644% |
| November, 2030 | $6.77 | $6.83 | $6.8581 | +1,545% |
| December, 2030 | $6.5392 | $6.6346 | $6.4873 | +1,489% |
4.27%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):